Notice of Annual Report and Accounts and Annual General Meeting7
Illumina to Announce Third Quarter 2009 Financial Results on Tuesday, October 27, 2009
Theratechnologies Announces Financial Results for the Third Quarter 2009
BIOMET ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL YEAR 2010
To keep up to date with news from this category use our
OraSure Announces 2009 Third Quarter Financial Results
BETHLEHEM, Pa., Nov. 4, 2009 -- OraSure Technologies, Inc. (Nasdaq:OSUR), a market leader in oral fluid diagnostics, today announced revenues of $21.6 million for the three months ended September 30, 2009, compared to...
Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66
MORRISTOWN, N.J., Nov. 4, 2009-- Watson Pharmaceuticals, Inc. (NYSE: WPI) today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended September 30, 2009. Excluding special items as...
Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results
NEEDHAM, Mass.--Nov. 4, 2009-- Celldex Therapeutics, Inc. (NASDAQ: CLDX) today reported financial results for the third quarter and nine-month period ended September 30, 2009. Celldex reported a net loss of $7.2...
Henry Schein Reports Record Third Quarter Results
MELVILLE, N.Y., November 4, 2009 -- Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter...
Given Imaging Reports Third Quarter 2009 Results
YOQNEAM, ISRAEL, November 04, 2009 -- Given Imaging Ltd. (NASDAQ: GIVN) today announced financial results for the third quarter ended September 30, 2009.
SurModics Reports Fourth Quarter and Fiscal Year 2009 Results
EDEN PRAIRIE, Minn.---Nov. 4, 2009-- SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, today reported financial results for the fourth...
Santarus Reports Third Quarter 2009 Financial Results
SAN DIEGO----Nov. 4, 2009-- Santarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today reported financial and operating results for the quarter ended September 30, 2009. Key financial results for the...
Chembio Reports Third Quarter 2009 Results
MEDFORD, NY, Nov 04, 2009 -- Chembio Diagnostics, Inc. (OTCBB: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, continued its profitability into the third quarter of 2009. Total...
Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results
CARY, N.C., Nov. 4 -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related...
Neurogen Corporation Announces Webcast of Third Quarter 2009 Financial Results on November 6
BRANFORD, Conn.-- November 4, 2009-- Neurogen Corporation (NASDAQ:NRGN), a drug development company, announced today that it will release its third quarter 2009 financial results on Friday, November 6, 2009 before the...
CML HealthCare Income Fund Announces Release Date for Fiscal 2009 Third Quarter Financial Results
MISSISSAUGA, ON, Nov. 4 - CML HealthCare Income Fund (TSX: CLC.UN), will release its 2009 third quarter financial results via www.newswire.ca prior to markets opening on November 11th , 2009. Following the release, CML...
Luminex Corporation Reports Third Quarter 2009 Results
AUSTIN, Texas-- November 4, 2009-- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the third quarter ended September 30, 2009. Recent financial and operating highlights include the following:
Bio-Rad Laboratories, Inc. (BIO) Reports Third-Quarter Currency-Neutral Revenue Growth of 11 Percent
HERCULES, CA--(November 03, 2009) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced financial...
AGA Medical Reports 2009 Third Quarter Financial Results
MINNEAPOLIS, Nov. 3, 2009 -- AGA Medical Holdings (NASDAQ: AGAM), a leading developer of interventional medical devices for the minimally invasive treatment of structural heart defects and vascular disease, today...
AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2009
BOSTON, Nov. 3 -- AMICAS, Inc. (NASDAQ: AMCS), a leader in image and information management solutions, today reported unaudited financial results for the third quarter ended September 30, 2009.
VIKING SYSTEMS, INC. REPORTS THIRD QUARTER RESULTS; PROVIDES BUSINESS UPDATES
Westborough, MA, November 3, 2009 -- Viking Systems, Inc. (OTCBB: VKNG.OB), a supplier of 2D and 3D visualization systems for the medical market, today announced results for the quarter ended September 30, 2009. The...
XenoPort Reports Third Quarter Financial Results
SANTA CLARA, Calif.---Nov. 3, 2009-- XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2009. Revenues for the third quarter were $0.4 million,...
VIVUS Reports Third Quarter 2009 Highlights and Financial Results
MOUNTAIN VIEW, Calif., Nov 03, 2009 -- VIVUS,Inc. (Nasdaq: VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today reported its highlights and financial...
Cyclacel Announces Third Quarter 2009 Financial Results
Berkeley Heights, NJ, November 3, 2009 - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") announced today financial and operating results for the third quarter of 2009. The...
Clarient Reports 2009 Third Quarter; Nine Month Results
ALISO VIEJO, Calif., Nov. 3 -- Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today reported financial...
Masimo Reports Third Quarter 2009 Financial Results
Irvine, California, November 3, 2009 - Masimo Corporation (NASDAQ: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced its financial results for the...
Third quarter 2009 report - Lundbeck records 20% growth, driven by Lundbeck Inc. and key products
November 03, 2009 -- H. Lundbeck A/S (Lundbeck) reports third quarter revenue of DKK 3,264 million growing 20% in constant exchange rates compared to the third quarter of 2008. Revenue in the US was DKK 959 million...
CardiacAssist expands market penetration of TandemHeart
PITTSBURGH, Nov. 2, 2009--Privately held CardiacAssist Inc. announced today that the Cardiovascular Institute of Stanford (University) Hospital & Clinics (Palo Alto, Calif.) is one of the newest cardiac centers to begin...
Questcor Announces Third Quarter 2009 Results
UNION CITY, Calif., Nov. 2, 2009-- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today reported financial results for its third quarter ended September 30, 2009. As previously reported on September 21, 2009, Questcor's...
Haemonetics Reports Double Digit Growth in Earnings for Second Quarter Fiscal 2010
Braintree, MA , November 2, 2009 - Haemonetics Corporation (NYSE: HAE) reported second quarter GAAP net revenues of $157 million, up 8%, net income of $18 million, up 22%, and earnings per share of $0.69, up 20%....
MANNKIND CORPORATION REPORTS THIRD QUARTER FINANCIAL RESULTS
November 02, 2009 -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the third quarter ended September 30, 2009.
MannKind Corporation Reports Third Quarter Financial Results
VALENCIA, Calif.-- November 2, 2009-- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the third quarter ended September 30, 2009.
Valeant Pharmaceuticals Reports Third Quarter Financial Results
ALISO VIEJO, Calif., Nov. 2, 2009-- Valeant Pharmaceuticals International (NYSE: VRX) today announced third quarter financial results for 2009.
Natus Medical Announces 2009 Third Quarter Financial Results and Increases Fourth Quarter and Full Year 2009 Guidance
SAN CARLOS, Calif., November 02, 2009 -- Natus Medical Incorporated (Nasdaq:BABY) today announced financial results for the three and nine months ended September 30, 2009.
UROPLASTY REPORTS RESULTS FOR SECOND QUARTER FY2010
MINNEAPOLIS, MN, November 2, 2009 - Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported...
Tredegar Reports Third-Quarter Results
RICHMOND, Va., Nov. 2 , 2009-- Tredegar Corporation (NYSE: TG) reported third-quarter net income from continuing operations of $11.0 million (32 cents per share) compared to $11.1 million (33 cents per share) in the...
Vanda Pharmaceuticals Reports Third Quarter 2009 Results
ROCKVILLE, Md., Nov 02, 2009 -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system...
Torrent Pharma's Q2 operating profits jump 83% at Rs. 118 crores
October 31st, 2009 - Ahmedabad-based Torrent Pharmaceuticals Limited, released its financial results for second quarter (Q2) and half year ended (H1) 30th September, 2009. The Q2 global sales stood at Rs. 465 crores, up...
Talecris Biotherapeutics to Report Third Quarter 2009 Financial Results
RESEARCH TRIANGLE PARK, N.C.---Oct. 30, 2009-- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) will release its third quarter 2009 financial results on November 9, 2009, after the stock market closes, and will...
Cytomedix To Host Third Quarter And Nine Months 2009 Financial Results Conference Call On Thursday, November 12, 2009
ROCKVILLE, Md. (October 30, 2009) - Cytomedix, Inc. (NYSE Amex: GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that the Company...
Pain Therapeutics Reports Third Quarter 2009 Results
SAN MATEO, Calif., Oct. 29, 2009 -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today reported financial results for the quarter ended September 30, 2009.
ALPHA PRO TECH, LTD. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2009
Nogales, Arizona - October 27, 2009, Alpha Pro Tech, Ltd. (NYSE Amex: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building...
Building Brands and gathering Momentum across Markets
Mumbai, October 26, 2009: Leading transnational pharmaceutical major Lupin, reported strong performance for the second quarter - FY 2009-10. These audited results were taken on record by the Board of Directors at a...
Valeant Pharmaceuticals to Announce 2009 Third Quarter Results on November 2, 2009
ALISO VIEJO, Calif., Oct. 23, 2009- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Monday, November...
Orthovita, Inc. (VITA) Announces 2009 Third Quarter Sales
MALVERN, Pa.--October 23, 2009--Orthovita, Inc. (NASDAQ:VITA), a leading orthobiologics and biosurgery company, today announced that product sales for the third quarter of 2009 were $22.3 million, an 8% increase over...
CONMED Corporation Announces Third Quarter 2009 Financial Results
UTICA, NY, Oct 22, 2009-- CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter of 2009.
Report of NicOx's financial results for the first three quarters of 2009
October 22, 2009. Sophia Antipolis, France. www.nicox.com NicOx S.A. (Euronext Paris: COX) today reported financial results for the nine months ended September 30, 2009.
ALPHA PRO TECH, LTD. TO ANNOUNCE 2009 THIRD QUARTER RESULTS ON OCTOBER 27, 2009
NOGALES, ARIZONA - October 21, 2009 -- Alpha Pro Tech, Ltd. (NYSE Amex: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and...
Trinity Biotech Announces Third Quarter 2009 Financial Results
DUBLIN, Ireland (October 21, 2009).... Trinity Biotech plc (NasdaqGS: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for...
Comment on Media Report on Forecast for AGC's Financial Results
October 21, 2009 Today's media report on the forecast for AGC's financial results for FY 2009 is not based on any announcement by AGC. AGC will announce the financial results for FY 2009 in February, 2010.
Genzyme Reports Third-Quarter Financial Results
October 21, 2009 - Genzyme Corp. (NASDAQ: GENZ) today reported that third-quarter revenue was $1.06 billion, compared with $1.16 billion in the same period a year ago. Results reflect the impact of the temporary...
API records strong growth and increased profit Announces $150m equity raising
October 21, 2009 Australian Pharmaceutical Industries (ASX: API), a leading Australian healthcare company and one of Australia's leading health and beauty retailers, today reported stronger than expected results for the...
UROPLASTY TO ISSUE SECOND FISCAL QUARTER RESULTS ON NOVEMBER 2, 2009
MINNEAPOLIS, MN, October 21, 2009 - Uroplasty, Inc. (AMEX: UPI) announced today that it will release financial results for the second fiscal quarter ended September 30, 2009, at the market close on Monday, November 2,...
Air Products Reports Fiscal Q4 EPS from Continuing Operations of $1.14
LEHIGH VALLEY, Pa. (October 21, 2009) - Air Products today reported income from continuing operations of $246 million, or diluted earnings per share (EPS) of $1.14, for its fiscal 2009 fourth quarter versus $273 million...
ERT to Announce 2009 Third Quarter Results on October 29, 2009
PHILADELPHIA, PA October 21, 2009 - ERT (NASDAQ: ERES), a leading provider of centralized ECG, ePRO, eClinical technology, and other services to the biopharmaceutical, medical device, and related industries, announced...
Bard Announces Third Quarter Results
MURRAY HILL, N.J.--Oct. 21, 2009-- C. R. Bard, Inc. (NYSE: BCR) today reported 2009 third quarter financial results. Third quarter 2009 net sales were $637.0 million, an increase of 3 percent over the prior-year period....
Privately held CardiacAssist reports record revenues for nine-month financial results Company's TandemHeart
PITTSBURGH, Oct. 19, 2009--Privately held CardiacAssist Inc. announced today nine-month financial results for 2009. TandemHeart System revenues were at new record levels compared to results for the same period in 2008.
Hansen Medical Announces Need to Restate Prior Financial Results
MOUNTAIN VIEW, CA, Oct 19, 2009 -- Hansen Medical, Inc. (NASDAQ: HNSN) today announced that it plans to restate its financial statements for the year ended December 31, 2008 and for the quarters ended March 31, 2008,...
Illumina to Announce Third Quarter 2009 Financial Results on Tuesday, October 27, 2009
SAN DIEGO-- October 14, 2009-- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2009 following the close of market on Tuesday, October 27, 2009.
Abbott Reports 16.5 Percent Earnings Growth in Third Quarter; Raises Earnings Guidance for 2009
Abbott Park, Illinois (NYSE: ABT) --October 14, 2009 Abbott today announced financial results for the third quarter ended Sept. 30, 2009.
Open Text to Report First Quarter Fiscal Year 2010 Financial Results on Tuesday, October 27, 2009
Waterloo, Ontario - October 14, 2009 - Open Text Corporation (NASDAQ:OTEX) (TSX:OTC), the leading independent provider of Enterprise Content Management (ECM) software, today announced that financial results for its...
Notice of Annual Report and Accounts and Annual General Meeting7
Southampton, UK - 14 October 2009: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company with a particular focus on viral defence in asthma and chronic obstructive pulmonary disease ('COPD'),...
Symyx Technologies to Announce Third Quarter 2009 Financial Results on October 28, 2009
SUNNYVALE, Calif., October 14, 2009 - Symyx Technologies, Inc. (Nasdaq: SMMX) announced today that it plans to release its third-quarter 2009 financial results after the close of market on Wednesday, October 28, 2009.
Gilead Sciences to Release Third Quarter 2009 Financial Results on Tuesday, October 20, 2009
FOSTER CITY, Calif.--Oct. 13, 2009-- Gilead Sciences, Inc. (Nasdaq:GILD) announced today that its third quarter 2009 financial results will be released on Tuesday, October 20, 2009, at 4:05 p.m. Eastern Time. At 4:30...
BIOMET ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL YEAR 2010
WARSAW, Ind., October 9, 2009 - Biomet, Inc. announced today financial results for its first fiscal quarter ended August 31, 2009.
Annual Report and Accounts 2009
9 October 2009, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Annual Report and Accounts for the year ended 30 June 2009 are available to view on the Company's website at...
NMT Medical, Inc (NMTI) to Release Third-Quarter 2009 Financial Results on October 29
October 09, 2009 -- BOSTON-- NMT Medical, Inc. (NASDAQ: NMTI) today announced that it will release its third-quarter 2009 financial results before the market opens on Thursday, October 29, 2009.
FONAR Deemed Compliant With All NASDAQ Capital Market Listing Standards; FONAR Complies with NASDAQ Marketplace Rule 5250(b)(2)
MELVILLE, NEW YORK, October 9, 2009 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning(TM), today announced that the NASDAQ Stock Market has notified FONAR that it complies with all NASDAQ Capital Market...
Annual Financial Report and AGM
October 09, 2009 -- The Annual Report and Accounts and Notice of Annual General Meeting are available on the Genus website at www.genusplc.com and these documents and the Proxy Form will be available for inspection at...
Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009
CHADDS FORD, Pa., October 8, 2009 -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its third quarter financial results on October 29, 2009 and will host a conference call and webcast at 9:00 a.m. ET that day to...
InSite Vision to Hold Annual Meeting of Stockholders
ALAMEDA, Calif.-- October 7, 2009-- InSite Vision Incorporated (OTCBB:INSV), a company developing ophthalmic products for unmet eye care needs, today announced that the company's Annual Meeting of Stockholders will be...
Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
SUNNYVALE, Calif., October 7, 2009 - Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its fiscal first quarter of 2010, ended September...
Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Medical Devices & Diagnostics Business
New Brunswick, NJ (October 6, 2009) - Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, Oct. 13, 2009, to discuss third-quarter financial results and review its Medical Devices &...
CONMED Corporation to Announce Third Quarter 2009 Financial Results on October 22, 2009
UTICA, NY, Oct 06, 2009 -- CONMED Corporation (NASDAQ: CNMD) announced today that it expects to report third quarter 2009 financial results before the market opens on Thursday, October 22, 2009, and will also hold a...
Chattem Reports Increased Revenues and Earnings; Affirms Fiscal 2009 Guidance
CHATTANOOGA, Tenn.--Oct. 6, 2009-- Chattem, Inc. (NASDAQ: CHTT), a leading marketer and manufacturer of branded consumer products, today announced financial results for the nine months and third fiscal quarter ended...
FONAR Reports Fiscal 2009 Year-End Financial Results Net Income Exceeds $1.1 Million
MELVILLE, NEW YORK, October 5, 2009 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning(TM), today announced its financial results for the fiscal year ending June 30, 2009. Total net income for the fiscal...
Theratechnologies Announces Financial Results for the Third Quarter 2009
Montr
Amarin Corporation PLC (AMRN) Receives Extension from Nasdaq to File Its 2008 Annual Report on Form 20-F
DUBLIN--October 05, 2009--Amarin Corporation plc (NASDAQ:AMRN) today announced that Nasdaq has granted the Company's requested extension to the deadline to file its 2008 Annual Report on Form 20-F with the U.S....
GENFIT: RESULTS FOR FIRST HALF OF 2009
Lille (France), Cambridge (Massachusetts, United States), October 2, 2009 - GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical company at the forefront of drug discovery and development, focusing on the...
Gentium Reports Second Quarter Financial Results; Provides Financial and Clinical Update
VILLA GUARDIA (COMO), Italy, September 17, 2009 -- Gentium S.p.A. (NASDAQ: GENT) today reported financial results for the second quarter ended June 30, 2009.
ConjuChem Announces Fiscal 2009 Third Quarter Financial Results
MONTREAL, Canada, September 14, 2009 - ConjuChem Biotechnologies (TSX:CJB) today announced financial results for the third quarter of fiscal 2009, ended July 31, 2009. "During our fiscal third quarter, we had the...
Second Quarter Report 2009
Oslo, Norway, 27 August 2009--During the second quarter Clavis Pharma announced the successful completion of a Phase II study of its lead development candidate, elacytarabine, in late-stage acute myeloid leukaemia...
HydroCision Announces Record Revenue Performance in Second Quarter
North Billerica, MA August 17, 2009-HydroCision Inc. (www.hydrocision.com) announced today that revenue for the second quarter of 2009 increased by 43% over the same fiscal quarter 2008. Trailing quarter product sales...
Hansen Medical Reports 2009 Second Quarter Results
MOUNTAIN VIEW, CA, August 04, 2009 -- Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in flexible medical robotics and the developer of robotic technology for accurate 3D control of catheter movement, today...
JT has Embarked on a Solid Start to Achieving its Fiscal Year Outlook Ending March 31, 2010
TOKYO, July 30, 2009 -- Japan Tobacco Inc. (JT) (TSE: 2914) announced today its consolidated financial results for the first quarter that ended June 30, 2009. While the first quarter net sales and EBITDA were negatively...
Almirall reports over 103 million euros net income in the first half year 2009
Barcelona, 30 July 2009.- Almirall, the international pharmaceutical company headquartered in Spain, publishes today its first half yearly results for fiscal year 2009, with net income totalling 103.4 million euros,...
WILLIAM RANSOM & SON PLC AUDITED PRELIMINARY RESULTS FOR THE YEAR ENDED 31 MARCH 2009
July 28, 2009-- William Ransom & Son plc ('Ransom'), the natural health products company, announces today its preliminary results for the year ended 31 March 2009.
FONAR GRANTED ADDITIONAL NASDAQ EXTENSION
MELVILLE, NEW YORK, June 29, 2009 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning
FONAR Announces Results of the Third Fiscal Quarter 2009 As Net Income Soars Past $1 Million for Nine Month Period
MELVILLE, NEW YORK, May 19, 2009 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning(TM), today announced its earnings for the third quarter of fiscal 2009 ending March 31, 2009. Net income for the nine month...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
